Kiely Wealth Advisory Group, Inc. Bristol Myers Squibb CO Transaction History
Kiely Wealth Advisory Group, Inc.
- $155 Billion
- Q4 2024
A detailed history of Kiely Wealth Advisory Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kiely Wealth Advisory Group, Inc. holds 344 shares of BMY stock, worth $20,646. This represents 0.01% of its overall portfolio holdings.
Number of Shares
344
Previous 344
-0.0%
Holding current value
$20,646
Previous $20.4 Million
6.48%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding BMY
# of Institutions
2,765Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.4 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.52 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.76 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.71 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.62 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $128B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...